Related Experiment Video
Updated: Jul 5, 2026

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
Published on: July 5, 2018
Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B
Mary K O'Reilly1, Brian E Collins, Shoufa Han
1Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, USA.
Insights
Researchers developed a synthetic molecule to target CD22 (a B cell regulator) using antibody scaffolds. This method efficiently assembles complexes on B cells, showing potential for targeting B cell malignancies.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- CD22 is a B cell-specific lectin regulating B cell signaling.
- Its function is modulated by specific sialic acid-containing glycan ligands (NeuAc α2-6Gal).
- Previously, only highly multivalent ligands (n=450) could bind CD22 on native B cells.
Purpose of the Study:
- To develop a synthetic molecule for efficient CD22 complex assembly on B cells.
- To investigate the role of antibody valency and ligand structure in CD22 binding.
- To explore the potential for targeted B cell therapy.
Main Methods:
- Synthesized bifunctional molecules linking CD22 ligands to nitrophenol (NP) antigens.
- Utilized monoclonal anti-NP IgM (decavalent), IgA (tetravalent), and IgG (divalent) as protein scaffolds.
- Analyzed complex formation on native B cells using varying linker lengths and structures.
Main Results:
- A synthetic CD22 ligand linked to NP efficiently drove IgM-CD22 complex assembly on B cells.
- Lower valency antibodies (IgA, IgG) also induced complex formation, albeit with reduced avidity.
- Ligand structure and linker length influenced complex assembly, with a minimal length requirement identified.
- Complex assembly was exclusive to CD22-expressing B cells, not other leukocytes.
Conclusions:
- Bifunctional molecules can leverage antibody scaffolds for targeted CD22 engagement on B cells.
- This approach offers a versatile strategy for modulating B cell surface interactions.
- The B cell-specific targeting capability holds promise for treating B cell malignancies.
Abstract:
CD22 is a B cell-specific sialic acid-binding immunoglobulin-like lectin (Siglec) whose function as a regulator of B cell signaling is modulated by its interaction with glycan ligands bearing the sequence NeuAc alpha2-6Gal. To date, only highly multivalent polymeric ligands (n = 450) have achieved sufficient avidity to bind to CD22 on native B cells. Here we demonstrate that a synthetic bifunctional molecule comprising a ligand of CD22 linked to an antigen (nitrophenol; NP) can use a monoclonal anti-NP IgM as a decavalent protein scaffold to efficiently drive assembly of IgM-CD22 complexes on the surface of native B cells. Surprisingly, anti-NP antibodies of lower valency, IgA (n = 4) and IgG (n = 2), were also found to drive complex formation, though with lower avidity. Ligands bearing alternate linkers of variable length and structure were constructed to establish the importance of a minimal length requirement, and versatility in the structural requirement. We show that the ligand drives assembly of IgM complexes exclusively on the surface of B cells and not other classes of white blood cells that do not express CD22, which lends itself to the possibility of targeting B cells in certain hematopoietic malignancies.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

